A Registry for People With T-cell Lymphoma
Recruiting at 25 trial locations
SH
AM
Overseen ByAlison Moskowitz, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.
Research Team
SH
Steven Horwitz, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
Inclusion Criteria
You have provided written authorization.
You have or are willing to obtain sufficient tumor tissue for analysis.
You have a long-term overproduction of natural killer cells.
See 7 more
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Participants with T-Cell LymphomaExperimental Treatment1 Intervention
Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Trials
1,998
Recruited
602,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.